Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -114.77% is 24% below its 5-year average of -92.39%, around the middle of its 5-year range (-181.81%–-26.44%).
8.88% above its 12-month average of -125.96%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -122.05%.
NET PROFIT MARGIN
-114.77%
NET PROFIT MARGIN AVG TTM
-125.96%
NET PROFIT MARGIN AVG 3Y
-112.03%
NET PROFIT MARGIN AVG 5Y
-92.39%
NET PROFIT MARGIN AVG 10Y
-75.97%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+8.88%
CURRENT VS 3Y AVG
-2.44%
CURRENT VS 5Y AVG
-24.22%
CURRENT VS 10Y AVG
-51.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MaxCyte, Inc.
Market Cap
$114.61M
Net Profit Margin
-114.77%
TTM Avg
-125.96%
3Y Avg
-112.03%
5Y Avg
-92.39%
Market Cap
$114.52M
Net Profit Margin
-959.76%
TTM Avg
-1140.14%
3Y Avg
-4837.22%
5Y Avg
-4160.74%
Market Cap
$115.02M
Net Profit Margin
-422412.50%
TTM Avg
-387587.50%
3Y Avg
-197966.84%
5Y Avg
-131977.89%
Market Cap
$113.61M
Net Profit Margin
-175.78%
TTM Avg
-311.79%
3Y Avg
-369.50%
5Y Avg
-4193.27%
Market Cap
$113.30M
Net Profit Margin
-270.22%
TTM Avg
-342.92%
3Y Avg
-204.73%
5Y Avg
-136.49%
Market Cap
$116.32M
Net Profit Margin
-1030.42%
TTM Avg
-1409.68%
3Y Avg
-958.30%
5Y Avg
-801.33%
Market Cap
$116.57M
Net Profit Margin
-2955.63%
TTM Avg
-2231.78%
3Y Avg
-3480.44%
5Y Avg
-3216.57%
Market Cap
$118.05M
Net Profit Margin
-586.74%
TTM Avg
-215.13%
3Y Avg
-125.58%
5Y Avg
-83.72%
Market Cap
$108.60M
Net Profit Margin
-52.59%
TTM Avg
-29.17%
3Y Avg
-18.36%
5Y Avg
-9.63%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MaxCyte, Inc. (MXCT) | $114.61M | -114.77% | -125.96% | -112.03% | -92.39% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.52M | -959.76% | -1140.14% | -4837.22% | -4160.74% |
| Genelux Corporation (GNLX)vs › | $115.02M | -422412.50% | -387587.50% | -197966.84% | -131977.89% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $113.61M | -175.78% | -311.79% | -369.50% | -4193.27% |
| Coya Therapeutics, Inc. (COYA)vs › | $113.30M | -270.22% | -342.92% | -204.73% | -136.49% |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.32M | -1030.42% | -1409.68% | -958.30% | -801.33% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $116.57M | -2955.63% | -2231.78% | -3480.44% | -3216.57% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.05M | -586.74% | -215.13% | -125.58% | -83.72% |
| BGM Group Ltd. (BGM)vs › | $108.60M | -52.59% | -29.17% | -18.36% | -9.63% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $110.05M | -4416.22% | -2208.11% | -1104.06% | -736.04% |
Operating Margin
-137.1%
Net Profit Margin
-114.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -122.05% |
| 2026-03-31 | -49.22% |
| 2025-12-31 | -131.45% |
| 2025-09-30 | -181.81% |
| 2025-06-30 | -145.26% |
| 2025-03-31 | -98.76% |
| 2024-12-31 | -121.90% |
| 2024-09-30 | -141.56% |
| 2024-06-30 | -89.89% |
| 2024-03-31 | -83.99% |
| 2023-12-31 | -33.69% |
| 2023-09-30 | -140.58% |
| 2023-06-30 | -116.24% |
| 2023-03-31 | -126.89% |
| 2022-12-31 | -38.71% |
| 2022-09-30 | -60.45% |
| 2022-06-30 | -85.97% |
| 2022-03-31 | -35.10% |
| 2021-12-31 | -48.01% |
| 2021-09-30 | -26.44% |
| 2021-06-30 | -62.21% |
| 2021-03-31 | -109.40% |
| 2020-12-31 | -31.15% |
| 2020-09-30 | -45.82% |
| 2020-06-30 | -58.33% |
| 2020-03-31 | -53.32% |
| 2019-12-31 | -25.82% |
| 2019-09-30 | -25.82% |
| 2019-06-30 | -113.15% |
| 2019-03-31 | -113.15% |
| 2018-12-31 | -41.93% |
| 2018-09-30 | -41.93% |
| 2018-06-30 | -69.07% |
| 2018-03-31 | -69.07% |
| 2017-12-31 | -72.24% |
| 2017-09-30 | -72.24% |
| 2017-06-30 | -69.25% |
| 2017-03-31 | -69.25% |
| 2016-12-31 | -30.56% |
| 2016-09-30 | -30.56% |
| 2016-06-30 | -32.41% |
| 2016-03-31 | -32.41% |
| 2015-12-31 | -30.01% |
| 2015-09-30 | -30.01% |
| 2015-06-30 | -47.40% |
| 2015-03-31 | -47.40% |
| 2014-12-31 | -39.56% |
| 2014-09-30 | -39.56% |
| 2014-06-30 | -70.62% |
| 2014-03-31 | -70.62% |
